|
Volumn 30, Issue 5, 1998, Pages 1869-1870
|
Treatment with PGE1 in patients after liver transplantation
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
PROSTAGLANDIN E1;
TACROLIMUS;
ALANINE AMINOTRANSFERASE;
FIBRINOLYTIC AGENT;
PLACEBO;
ADULT;
BLOOD OXYGENATION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
GRAFT SURVIVAL;
HEART OUTPUT;
HUMAN;
INFUSION;
LIVER CIRCULATION;
LIVER CIRRHOSIS;
LIVER ISCHEMIA;
LIVER TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
REPERFUSION;
SPLANCHNIC BLOOD FLOW;
AGED;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG EFFECT;
HEMODYNAMICS;
MIDDLE AGED;
MORTALITY;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL RATE;
ADULT;
AGED;
ALANINE TRANSAMINASE;
ALPROSTADIL;
FEMALE;
FIBRINOLYTIC AGENTS;
GRAFT SURVIVAL;
HEMODYNAMIC PROCESSES;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PLACEBOS;
SURVIVAL RATE;
|
EID: 13144294070
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00464-3 Document Type: Conference Paper |
Times cited : (9)
|
References (7)
|